Friday, January 16, 2026 8:59:26 PM
In addition to Chuigray's outstanding takedown of Hygro's argument (Chuigray's posts are not to be missed, as longtime longs here know), there's a common sense element that I believe is underplayed.
The initial submission occurred two years ago. What we are asked to believe is after all that time the company would get a response like this from the MHRA: "Northwest Bio, hey, we've been mulling this over for a couple years, hemming and hawing, and we've decided the ECAs just aren't going to work for us. Yes, when Linda Powers noted in the last shareholder's meeting that 'we are really, really gratified by how much work and how much resources the agency is devoting to our case,' it makes us realize that we have wasted an incredible amount of time and resources, which could have been spent getting other life saving and extending treatments to patients, which is unfortunate, but just can't get there. You might want to withdraw your application now."
Sound likely?
The initial submission occurred two years ago. What we are asked to believe is after all that time the company would get a response like this from the MHRA: "Northwest Bio, hey, we've been mulling this over for a couple years, hemming and hawing, and we've decided the ECAs just aren't going to work for us. Yes, when Linda Powers noted in the last shareholder's meeting that 'we are really, really gratified by how much work and how much resources the agency is devoting to our case,' it makes us realize that we have wasted an incredible amount of time and resources, which could have been spent getting other life saving and extending treatments to patients, which is unfortunate, but just can't get there. You might want to withdraw your application now."
Sound likely?
Recent NWBO News
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
